<%server.execute "isdev.asp"%> Diffuse leptomeningeal spread of supratentorial recurrent pilocytic astrocytoma in a child Raheja A, Singh PK, Nambirajan A, Sharma MC, Sharma BS - J Pediatr Neurosci
home : about us : ahead of print : current issue : archives search instructions : subscriptionLogin 
Users online: 238      Small font sizeDefault font sizeIncrease font size Print this page Email this page


 
  Table of Contents    
LETTER TO THE EDITOR
Year : 2015  |  Volume : 10  |  Issue : 4  |  Page : 408-411
 

Diffuse leptomeningeal spread of supratentorial recurrent pilocytic astrocytoma in a child


1 Department of Neurosurgery and Gamma Knife, All Institute of Medical Sciences, New Delhi, India
2 Department of Neuropathology, All Institute of Medical Sciences, New Delhi, India

Date of Web Publication20-Jan-2016

Correspondence Address:
Pankaj Kumar Singh
Department of Neurosurgery and Gamma Knife, Room No - 717, Neurosciences Centre, All India Institute of Medical Sciences, New Delhi
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1817-1745.174452

Rights and Permissions

 



How to cite this article:
Raheja A, Singh PK, Nambirajan A, Sharma MC, Sharma BS. Diffuse leptomeningeal spread of supratentorial recurrent pilocytic astrocytoma in a child. J Pediatr Neurosci 2015;10:408-11

How to cite this URL:
Raheja A, Singh PK, Nambirajan A, Sharma MC, Sharma BS. Diffuse leptomeningeal spread of supratentorial recurrent pilocytic astrocytoma in a child. J Pediatr Neurosci [serial online] 2015 [cited 2019 Oct 19];10:408-11. Available from: http://www.pediatricneurosciences.com/text.asp?2015/10/4/408/174452


Dear Sir,

Pilocytic astrocytoma (PA) constitutes a significant proportion (25%) of pediatric primary brain tumors.[1],[2] It primarily involves infratentorial compartment (vermis, cerebellar hemisphere), thalamus, hypothalamus, and optic pathway.[2],[3],[4] Supratentorial intraventricular location in young age (<3 years) is exceedingly rare.[2],[3],[4],[5] Natural history of PA is typically benign with favorable long-term outcome,[3] except rarely reported more aggressive clinical course.[1],[6],[7],[8],[9],[10] Clinical factors predicting outcome in PA include age, location, and extent of resection.[1],[3],[6],[11] Histopathological and molecular parameters predicting outcome include p53 status, oligodendroglioma like features, calcification, vascular hyalinization, matrilin-2, and aldehyde dehydrogenase 1 family member L1 levels.[2],[11],[12],[13],[14],[15] Recent studies have pointed towards role of PI3K/AKT pathway activation in addition to mitogen-activated protein kinases/extracellular-signal-regulated kinase signaling pathway in biologically aggressive PA variants.[12] Differentiating classic PA from aggressive pilomyxoid astrocytoma variant (PMA) and anaplastic transformation is of paramount importance for prognostication and treatment algorithm.[16],[17] Three patterns of recurrence in PA are local recurrence, malignant transformation on long-term surveillance (usually > 10 years) and least commonly observed metastatic/multicentric disease on short-term surveillance.[18] We report an unusual case of recurrent supratentorial intraventricular PA presenting with a large local recurrence along with grossly disseminated disease along complete neuraxis in short span of 1 year following primary surgery.

Index case presented at 3 years age with delayed developmental milestones and increasing head size. Imaging [Figure 1] demonstrated supratentorial intraventricular lesion. Tumor decompression was done leaving small residual along posterior third ventricle [Figure 1]. Biopsy confirmed PA with 1% Milano Italia Borsa index. Owing to benign histopathological features and young age, decision to perform close follow-up was taken. He again presented within 1 year with rapidly increasing head size, recurrent vomiting and left-sided weakness. Imaging [Figure 2] showed local recurrence with metastatic deposits along entire neuraxis. Perfusion imaging [Figure 2] ruled out malignant transformation. Tumor debulking of recurrent lesion revealed recurrent PA [Figure 3]. Adjuvant chemo- and radiotherapy was given in view of widely metastatic disease. Retrospective evaluation of initial preoperative scans showed a small enhancing lesion in prepontine cistern, thereby suggesting rare synchronous, multifocal nature of PA at presentation.
Figure 1: Preoperative gadolinium magnetic resonance imaging contrast-enhanced magnetic resonance imaging brain axial, (a) coronal (b) and sagittal (c) sections demonstrating large, heterogeneously enhancing, predominantly solid, intraventricular lesion (thick arrow) in right lateral ventricle with posterior third ventricular extension and accompanying hydrocephalus. Small prepontine homogenously enhancing lesion (thin arrow) is suggestive of synchronous nature of disease. Postoperative contrast-enhanced magnetic resonance imaging brain axial, (d) coronal (e) and sagittal (f) sections demonstrating resolution of hydrocephalus, development of right subdural hygroma, residual primary lesion (thick arrow) in posterior third ventricular region with infratentorial growth and accompanying satellite nodules in posterior fossa and increasing synchronous primary lesion (thin arrow)

Click here to view
Figure 2: (a) Postoperative perfusion imaging confirmed no significant increase in relative cerebral blood volume (thick white arrow) in recurrent lesion. Follow-up contrast-enhanced magnetic resonance imaging brain axial, (b) coronal (c) and sagittal (d) sections demonstrating intensely enhancing, solid local recurrence in posterior third ventricle region (thick arrow), distant synchronous recurrence in prepontine cistern (thin arrow) along with multiple, nodular, metastatic deposits (thin arrow) along ependymal lining and diffuse uniform leptomeningeal enhancement in the entire neuraxis as highlighted in screening contrast-enhanced magnetic resonance imaging whole spine (e)

Click here to view
Figure 3: (a) Tumor with compact and microcystic areas, H and E, ×100; (b) mild to moderate nuclear pleomorphism with giant cells and hyalinized blood vessels, H and E, ×200; tumor cells were immunopositive for gial fibrillary acidic protein (c) while they were negative for p53, (d) isocitrate dehydrogenase-1. (e) There is no loss of ATRX immunoexpression. (f) The Milano Italia Borsa-1 labelling index is low (g)

Click here to view


Leptomeningeal disease (LD) is essentially a hallmark of malignant lesions.[19] Reported incidence of LD in low-grade glioma varies from 4% to 12%, 5% of them presenting at initial presentation.[20],[21] Factors predisposing for LD include tumor location adjacent to cerebrospinal fluid (CSF) space, antigenic profile, degree of adhesiveness, CD44 expression and metabolic pattern (protease secretion and growth factor pathway activation).[9], 18, [22],[23],[24] It usually presents with hydrocephalus, meningismus, focal neurological deficit, or seizure.[7] High-risk areas for LD include basilar cistern, sylvian fissure, and cauda equina, being gravity dependent areas and having sluggish CSF flow.[19] Amplification of epidermal growth factor receptor gene located at short arm of chromosome 7 has been recently attributed to pathophysiology for LD, making it a potential target for alteration of natural history in high-risk cases.[25] PA usually presents with a stereotypic radiographic pattern of cyst with a mural nodule, predominantly solid lesion with minimal cystic component is seen in <17% of cases.[13] Clinical-pathologic dissociation is an area of ongoing debate in selective subgroup of PA patients having atypical natural history despite benign histological features. Histological differentiation from more aggressive PMA phenotype (common in infants and young children) can be done based on more monomorphous and myxoid character, absence of Rosenthal fibers and eosinophilic granular bodies in PMA.[17] Another close differential is anaplastic PA, characterized by hypercellularity, moderate to severe cellular atypia, brisk mitotic activity (>4/high-power field) with or without necrosis.[16],[26]

Screening of entire neuraxis is warranted in intraventricular lesions despite benign natural history. Since CSF evaluation yields inconsistent results in LD, gadolinium magnetic resonance imaging is considered gold standard for its diagnosis.[27] Treatment of LD in PA is typically adjuvant in form of multi-agent chemotherapy, radiotherapy or stereotactic radiosurgery.[28],[29],[30] To conclude, solid supratentorial intraventricular PA presenting as recurrent disseminated LD in less than a year is unusual and highlights importance of early surveillance in large lesions having intraventricular locations for timely adjuvant therapy and optimal outcome.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
   References Top

1.
Stüer C, Vilz B, Majores M, Becker A, Schramm J, Simon M. Frequent recurrence and progression in pilocytic astrocytoma in adults. Cancer 2007;110:2799-808.  Back to cited text no. 1
    
2.
Tibbetts KM, Emnett RJ, Gao F, Perry A, Gutmann DH, Leonard JR. Histopathologic predictors of pilocytic astrocytoma event-free survival. Acta Neuropathol 2009;117:657-65.  Back to cited text no. 2
    
3.
Cyrine S, Sonia Z, Mounir T, Badderedine S, Kalthoum T, Hedi K, et al. Pilocytic astrocytoma: A retrospective study of 32 cases. Clin Neurol Neurosurg 2013;115:1220-5.  Back to cited text no. 3
    
4.
Malik A, Deb P, Sharma MC, Sarkar C. Neuropathological spectrum of pilocytic astrocytoma: An Indian series of 120 cases. Pathol Oncol Res 2006;12:164-71.  Back to cited text no. 4
    
5.
Devi BI, Shukla D, Bhat D, Santosh V. Hypothalamic tumour with haemorrhage. Childs Nerv Syst 2001;17:567-9.  Back to cited text no. 5
    
6.
Tihan T, Ersen A, Qaddoumi I, Sughayer MA, Tolunay S, Al-Hussaini M, et al. Pathologic characteristics of pediatric intracranial pilocytic astrocytomas and their impact on outcome in 3 countries: A multi-institutional study. Am J Surg Pathol 2012;36:43-55.  Back to cited text no. 6
    
7.
Redhu R, Nadkarni TD. Multicompartmental cerebrospinal fluid dissemination of cerebellar pilocytic astrocytoma at presentation. J Clin Neurosci 2011;18:1412-4.  Back to cited text no. 7
    
8.
Bell WO, Packer RJ, Seigel KR, Rorke LB, Sutton LN, Bruce DA, et al. Leptomeningeal spread of intramedullary spinal cord tumors. Report of three cases. J Neurosurg 1988;69:295-300.  Back to cited text no. 8
    
9.
Gajjar A, Bhargava R, Jenkins JJ, Heideman R, Sanford RA, Langston JW, et al. Low-grade astrocytoma with neuraxis dissemination at diagnosis. J Neurosurg 1995;83:67-71.  Back to cited text no. 9
    
10.
Kanoke A, Kanamori M, Kumabe T, Saito R, Watanabe M, Tominaga T. Metachronous, multicentric glioma of pilocytic astrocytoma with oligodendroglioma-like component and oligodendroglioma through distinct genetic aberrations. J Neurosurg 2013;118:854-8.  Back to cited text no. 10
    
11.
Fernandez C, Figarella-Branger D, Girard N, Bouvier-Labit C, Gouvernet J, Paz Paredes A, et al. Pilocytic astrocytomas in children: Prognostic factors – a retrospective study of 80 cases. Neurosurgery 2003;53:544-53.  Back to cited text no. 11
    
12.
Rodriguez EF, Scheithauer BW, Giannini C, Rynearson A, Cen L, Hoesley B, et al. PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma. Acta Neuropathol 2011;121:407-20.  Back to cited text no. 12
    
13.
Murray RD, Penar PL, Filippi CG, Tarasiewicz I. Radiographically distinct variant of pilocytic astrocytoma: A case series. J Comput Assist Tomogr 2011;35:495-7.  Back to cited text no. 13
    
14.
Rodriguez FJ, Giannini C, Asmann YW, Sharma MK, Perry A, Tibbetts KM, et al. Gene expression profiling of NF-1-associated and sporadic pilocytic astrocytoma identifies aldehyde dehydrogenase 1 family member L1 (ALDH1L1) as an underexpressed candidate biomarker in aggressive subtypes. J Neuropathol Exp Neurol 2008;67:1194-204.  Back to cited text no. 14
    
15.
Sharma MK, Watson MA, Lyman M, Perry A, Aldape KD, Deák F, et al. Matrilin-2 expression distinguishes clinically relevant subsets of pilocytic astrocytoma. Neurology 2006;66:127-30.  Back to cited text no. 15
    
16.
Rodriguez FJ, Scheithauer BW, Burger PC, Jenkins S, Giannini C. Anaplasia in pilocytic astrocytoma predicts aggressive behavior. Am J Surg Pathol 2010;34:147-60.  Back to cited text no. 16
    
17.
Tihan T, Fisher PG, Kepner JL, Godfraind C, McComb RD, Goldthwaite PT, et al. Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome. J Neuropathol Exp Neurol 1999;58:1061-8.  Back to cited text no. 17
    
18.
Mamelak AN, Prados MD, Obana WG, Cogen PH, Edwards MS. Treatment options and prognosis for multicentric juvenile pilocytic astrocytoma. J Neurosurg 1994;81:24-30.  Back to cited text no. 18
    
19.
Abel TJ, Chowdhary A, Thapa M, Rutledge JC, Geyer JR, Ojemann J, et al. Spinal cord pilocytic astrocytoma with leptomeningeal dissemination to the brain. Case report and review of the literature. J Neurosurg 2006;105 6 Suppl: 508-14.  Back to cited text no. 19
    
20.
Perilongo G, Garrè ML, Giangaspero F. Low-grade gliomas and leptomeningeal dissemination: A poorly understood phenomenon. Childs Nerv Syst 2003;19:197-203.  Back to cited text no. 20
    
21.
Pollack IF, Hurtt M, Pang D, Albright AL. Dissemination of low grade intracranial astrocytomas in children. Cancer 1994;73:2869-78.  Back to cited text no. 21
    
22.
Cooper DL, Dougherty GJ. To metastasize or not? Selection of CD44 splice sites. Nat Med 1995;1:635-7.  Back to cited text no. 22
    
23.
Kellie SJ, Kovnar EH, Kun LE, Horowitz ME, Heideman RL, Douglass EC, et al. Neuraxis dissemination in pediatric brain tumors. Response to preirradiation chemotherapy. Cancer 1992;69:1061-6.  Back to cited text no. 23
    
24.
Prados M, Mamelak AN. Metastasizing low grade gliomas in children. Redefining an old disease. Cancer 1994;73:2671-3.  Back to cited text no. 24
    
25.
Tabori U, Rienstein S, Dromi Y, Leider-Trejo L, Constantini S, Burstein Y, et al. Epidermal growth factor receptor gene amplification and expression in disseminated pediatric low-grade gliomas. J Neurosurg 2005;103 4 Suppl: 357-61.  Back to cited text no. 25
    
26.
Krieger MD, Gonzalez-Gomez I, Levy ML, McComb JG. Recurrence patterns and anaplastic change in a long-term study of pilocytic astrocytomas. Pediatr Neurosurg 1997;27:1-11.  Back to cited text no. 26
    
27.
Kramer ED, Rafto S, Packer RJ, Zimmerman RA. Comparison of myelography with CT follow-up versus gadolinium MRI for subarachnoid metastatic disease in children. Neurology 1991;41:46-50.  Back to cited text no. 27
    
28.
Aryan HE, Meltzer HS, Lu DC, Ozgur BM, Levy ML, Bruce DA. Management of pilocytic astrocytoma with diffuse leptomeningeal spread: Two cases and review of the literature. Childs Nerv Syst 2005;21:477-81.  Back to cited text no. 28
    
29.
Tamura M, Zama A, Kurihara H, Fujimaki H, Imai H, Kano T, et al. Management of recurrent pilocytic astrocytoma with leptomeningeal dissemination in childhood. Childs Nerv Syst 1998;14:617-22.  Back to cited text no. 29
    
30.
Hallemeier CL, Pollock BE, Schomberg PJ, Link MJ, Brown PD, Stafford SL. Stereotactic radiosurgery for recurrent or unresectable pilocytic astrocytoma. Int J Radiat Oncol Biol Phys 2012;83:107-12.  Back to cited text no. 30
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]



 

Top
Print this article  Email this article
 
 
  Search
 
  
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (418 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References
    Article Figures

 Article Access Statistics
    Viewed938    
    Printed7    
    Emailed0    
    PDF Downloaded66    
    Comments [Add]    

Recommend this journal